Skip to main content
VISEN Pharmaceuticals logo

VISEN Pharmaceuticals — Investor Relations & Filings

Ticker · 2561 ISIN · KYG9363A1003 LEI · 254900OJ8HIP6GRV1044 HKEX Manufacturing
Open in API
Filings indexed 67 across all filing types
Latest filing 2025-08-15 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2561

About VISEN Pharmaceuticals

http://www.visenpharma.com

VISEN Pharmaceuticals is an innovative biopharmaceutical company focused on the development and commercialization of paradigm-shifting therapies for endocrine diseases. The company is committed to addressing unmet medical needs within the Greater China market by providing innovative treatments and compassionate patient care. VISEN's core strategy involves leveraging advanced drug delivery platforms, which utilize prodrugs connected to carrier molecules via a linker structure. This technology enables the controlled, slow release of the unmodified prototype drug, ensuring sustained therapeutic action while the linker and carrier are safely excreted. VISEN serves as a key strategic partner for global biopharma companies seeking to commercialize high-quality endocrine assets in the region.

Recent filings

Filing Released Lang Actions
DATE OF BOARD MEETING
Regulatory Filings Classification · 75% confidence The document is a notice of the board meeting date for approving interim results, with no actual financials provided. It does not announce a change in management (MANG), nor attach or publish the interim report itself (so not RPA), but is a routine regulatory announcement by the listed company. This best fits the fallback category “Regulatory Filings” (RNS).
2025-08-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025
Share Issue/Capital Change Classification · 85% confidence The document is an HKEX Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” under Chapter 19B of the Listing Rules, detailing movements in authorized share capital, issued shares, treasury shares, share options, awards, warrants, and other capital arrangements. It is not an annual or interim financial report, nor an earnings release, board change announcement, or voting result. The content focuses exclusively on share capital movements and issuance details, which falls under the category of Share Issue/Capital Change (Code: SHA).
2025-08-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025
Share Issue/Capital Change Classification · 85% confidence The document is a Hong Kong Exchange monthly return (Form FF301) detailing movements in authorised share capital, issued shares, treasury shares, and related share schemes for the month ended 30 June 2025. It is not a periodic financial performance report (e.g., 10-K, IR) nor an initial earnings release, but a regulatory filing concerning share capital movements. The content falls squarely under announcements of share capital changes and issuance activities. Therefore, it best fits the Share Issue/Capital Change category (Code: SHA).
2025-07-07 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Governance Information Classification · 75% confidence The document provides a detailed listing of the company’s board of directors and their committee memberships, outlining the board structure and governance framework rather than announcing a specific change in personnel or providing proxy materials. This aligns with the Governance Information category, which covers reports detailing internal rules, board structure, and governance practices.
2025-06-27 English
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 27 JUNE 2025&#x3b; (2) RETIREMENT OF NON-EXECUTIVE DIRECTORS&#x3b; (3) CHANGE OF CHAIRMAN OF THE BOARD&#x3b; AND (4) CHANGE OF COMPOSITION OF NOM
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a Hong Kong Stock Exchange announcement detailing the poll results of the company’s Annual General Meeting (AGM) held on 27 June 2025 (showing votes for and against each resolution). It then reports retirements of non-executive directors, election of a new Chairman, and changes to the nomination committee—information that follows directly from the shareholder votes. The primary focus is the publication of voting outcomes from the AGM. According to definitions, “Declaration of Voting Results & Voting Rights Announcements (Code: DVA)” covers official results from shareholder votes at any general meeting (AGM or EGM). Therefore this is classified as DVA.
2025-06-27 English
Documents on Display
Regulatory Filings Classification · 95% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2025-06-13 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.